Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 50.76 | N/A |
| PEG Ratio (TTM) | 0.25 | N/A |
| P/S Ratio (TTM) | 8.05 | N/A |
| P/B Ratio (TTM) | 1.65 | N/A |
| P/FCF Ratio (TTM) | 24.85 | N/A |
| Price to 5YR AVG Earnings Ratio | 764.59 | N/A |
| Price to 5YR AVG FCF Ratio | 36.77 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.86% | N/A |
| ROE (TTM) | 3.70% | N/A |
| Net Profit Margin (TTM) | 15.19% | N/A |
| ROIC 5YR AVG | 3.80% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 485.03% | 58.55% | 13.24% |
| Revenue | -19.51% | 12.83% | 11.31% |
| Net Income | 333.31% | 67.05% | 25.26% |
| Cash Flow | 25.89% | 23.17% | 312.28% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 12.07 | N/A |
| Quick Ratio (TTM) | 10.35 | N/A |
| D/E Ratio (TTM) | 0.72 | N/A |
| Interest Coverage (TTM) | 0.00 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.78 | N/A |
| LTL to 5YR AVG FCF | 17.16 | N/A |
| Shares Outstanding Growth 5YR AVG | 11.45% | N/A |